Literature DB >> 15138200

Endoscopic therapy of Barrett's: what more do we need to know?

J-L Van Laethem1, J Devière.   

Abstract

Results emerging from endoscopic treatments to ablate Barrett's oesophagus indicate that APC alone or ALA-PDT in combination with APC achieves complete clearance of Barrett's epithelium in approximately two thirds of patients.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15138200      PMCID： PMC1774062          DOI： 10.1136/gut.2003.036392

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  12 in total

1.  Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation.

Authors:  A Shand; H Dallal; K Palmer; S Ghosh; M MacIntyre
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.

Authors:  H Schulz; S Miehlke; D Antos; K U Schentke; M Vieth; M Stolte; E Bayerdörffer
Journal:  Gastrointest Endosc       Date:  2000-06       Impact factor: 9.427

Review 3.  Photodynamic therapy in Barrett's esophagus.

Authors:  Kenneth K Wang; John Y Kim
Journal:  Gastrointest Endosc Clin N Am       Date:  2003-07

4.  Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.

Authors:  M Kahaleh; J-L Van Laethem; N Nagy; M Cremer; J Devière
Journal:  Endoscopy       Date:  2002-12       Impact factor: 10.093

5.  Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus.

Authors:  J L Van Laethem; M O Peny; I Salmon; M Cremer; J Devière
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

6.  Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium.

Authors:  K K Basu; B Pick; R Bale; K P West; J S de Caestecker
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

7.  Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy.

Authors:  K K Krishnadath; K K Wang; K Taniguchi; T J Sebo; N S Buttar; M A Anderson; L S Lutzke; W Liu
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

8.  Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression.

Authors:  R Ouatu-Lascar; R C Fitzgerald; G Triadafilopoulos
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

9.  5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.

Authors:  M Hage; P D Siersema; H van Dekken; E W Steyerberg; J Haringsma; W van de Vrie; T E Grool; R L P van Veen; H J C M Sterenborg; E J Kuipers
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 10.  Argon plasma coagulation in Barrett's esophagus.

Authors:  Denis Franchimont; Jean-Luc Van Laethem; Jacques Devière
Journal:  Gastrointest Endosc Clin N Am       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.